Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TRDA |
---|---|---|
09:32 ET | 1378 | 17.5 |
09:34 ET | 100 | 17.35 |
09:45 ET | 300 | 17.515 |
09:54 ET | 100 | 17.605 |
09:57 ET | 400 | 17.53 |
10:03 ET | 405 | 17.245 |
10:06 ET | 100 | 17.36 |
10:08 ET | 1200 | 17.285 |
10:21 ET | 332 | 17.04 |
10:26 ET | 100 | 17.04 |
10:33 ET | 600 | 16.9655 |
10:37 ET | 100 | 16.995 |
10:44 ET | 289 | 17.22 |
10:50 ET | 998 | 17.2 |
10:51 ET | 300 | 17.16 |
10:55 ET | 100 | 17.185 |
11:02 ET | 1595 | 17.02 |
11:11 ET | 100 | 17.13 |
11:15 ET | 100 | 17.09 |
11:24 ET | 100 | 17.13 |
11:26 ET | 300 | 17.08 |
11:27 ET | 100 | 17.19 |
11:33 ET | 300 | 17.12 |
11:47 ET | 100 | 17.26 |
11:51 ET | 100 | 17.13 |
11:54 ET | 100 | 17.225 |
11:56 ET | 500 | 17.14 |
12:00 ET | 100 | 17.17 |
12:02 ET | 200 | 17.18 |
12:12 ET | 700 | 17.125 |
12:30 ET | 200 | 17.07 |
12:52 ET | 200 | 17.07 |
12:54 ET | 1998 | 16.92 |
01:03 ET | 100 | 16.995 |
01:06 ET | 780 | 16.99 |
01:08 ET | 117 | 16.995 |
01:12 ET | 300 | 17.06 |
01:14 ET | 100 | 17.015 |
01:35 ET | 800 | 16.965 |
01:42 ET | 321 | 16.9 |
02:02 ET | 200 | 17.05 |
02:04 ET | 230 | 17.06 |
02:15 ET | 100 | 17.05 |
02:26 ET | 300 | 17.065 |
02:56 ET | 1218 | 17.1 |
03:05 ET | 300 | 17 |
03:07 ET | 958 | 17.04 |
03:09 ET | 100 | 17.015 |
03:12 ET | 100 | 17.01 |
03:14 ET | 600 | 17.07 |
03:16 ET | 100 | 17.12 |
03:21 ET | 100 | 17.15 |
03:25 ET | 400 | 17.24 |
03:27 ET | 100 | 17.27 |
03:30 ET | 700 | 17.19 |
03:38 ET | 600 | 17.195 |
03:39 ET | 100 | 17.195 |
03:43 ET | 979 | 17.18 |
03:45 ET | 200 | 17.195 |
03:48 ET | 200 | 17.18 |
03:50 ET | 1000 | 17.18 |
03:52 ET | 3076 | 17.22 |
03:54 ET | 400 | 17.25 |
03:56 ET | 1196 | 17.18 |
03:57 ET | 3330 | 17.2 |
03:59 ET | 1758 | 17.22 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Entrada Therapeutics Inc | 632.2M | 27.5x | --- |
Avid Bioservices Inc | 656.2M | -4.6x | --- |
Heron Therapeutics Inc | 467.0M | -5.0x | --- |
Travere Therapeutics Inc | 743.8M | -1.9x | --- |
Alector Inc | 625.5M | -4.7x | --- |
WAVE Life Sciences Ltd | 771.6M | -12.7x | --- |
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a class of medicines, which engages intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through its proprietary, highly versatile and modular EEV platform (EEV Platform), the Company is building a robust development portfolio of therapeutic candidates. Its first two drug candidates, ENTR-601-44 and VX-670, are in clinical trials. VX-670 for dystrophy type 1 (DM1) is designed to block the triplet repeats in the messenger RNA (mRNA). ENTR-601-44 is in a Phase I clinical trial. The Company also announced the selection of additional clinical candidates within its Duchenne franchise, ENTR-601-45 and ENTR-601-50.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $632.2M |
---|---|
Revenue (TTM) | $162.9M |
Shares Outstanding | 37.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.63 |
Book Value | $7.25 |
P/E Ratio | 27.5x |
Price/Sales (TTM) | 3.9 |
Price/Cash Flow (TTM) | 23.6x |
Operating Margin | 14.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.